skip to primary navigationskip to content

Drug Discovery and Development (3D) Workshop

This Pfizer 3D game enables all participants to collaborate throughout a computer simulated drug development process from pre-clinical research through to final product approval from the FDA.
When Jul 11, 2018
from 11:00 AM to 04:00 PM
Where Seminar Room B, First Floor 17 Mill Lane, Cambridge, CB2 1RX
Add event to calendar vCal

Attendance is free but strictly limited to 25 participants – please register with to reserve your place.

Participants work as an industrial project team, trying to get a great drug to patients. This workshop is a tailored version of a training system that is regularly provided to senior Pfizer R&D scientists and project team leaders.

The facilitator will guide the interactive session using a computer programme simulating the entire spectrum of R&D process based decisions (from target selection, in vivo & safety studies, IND filing, to clinical trial strategy and regulatory interactions).

During the game, your team will encounter decision points and then work together and engage in debate on how to move forward. These decisions will be influenced by data and test results produced by the simulation.

Your decisions and the related outcomes will affect overall quality and competitiveness of your program as reflected by R&D cost, patent/product life and time to market.

About the speaker: Nick leads Pfizer’s UK Academic interactions with the academic & medical institutions of the UK in identifying potential collaborations in the areas of biological space of interest to Pfizer’s Research Units.

This includes overseeing the formation of Innovative Target Exploration Networks (ITEN) of investigators to identify and validate targets including academic medical institutions such as the University of Cambridge.

Nick has a wide breadth of experience across the preclinical and clinical phase of drug discovery and development and in a variety of therapeutic areas including allergy, respiratory, inflammation and rare disease.

Nick has over 20 years’ pharmaceutical and 5 years’ academic experience and obtained his PhD in Anatomical Neuropharmacology at the University of Oxford in 1997 following his Bachelor’s degree in Pharmacology.

Who Should Participate: Researchers and academics who are interested in developing a deep appreciation of the decision processes, cost and timeline for new drug R&D; hands on experience in the drug R&D is preferred but not a must.

Register for the event: This workshop is free to attend and 25 places are available. Places will be filled on a first come-first served basis. Please email Dr Ruchi Chauhan from the Cambridge Academy of Therapeutic Sciences at to reserve your place.

OPdA Tweets

RSS Feed Latest news

Language courses now available at the Biomedical Campus

Sep 21, 2018

This year the University of Cambridge Language Centre will be running lunchtime language courses at the Postdoc Centre @ Biomedical Campus.

Join the Shaping Horizons 2019 committee as a webmaster

Sep 10, 2018

Shaping Horizons 2019 is looking for a webmaster to manage and improve their webpage.

Visa Loan Scheme now available

Sep 07, 2018

The University has launched a new visa loan scheme for all current and prospective staff, and their dependants, who hold or require a Tier 2 visa sponsored by the University.

View all news